Friday, November 27, 2015 5:36:10 PM
10K December 2014 when Brent took over:
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10627409
Authorized 10,000,000,000 shares at par value of $ 0.00001 each
Issued and outstanding 46,256,568 shares as of December 31, 2014
10Q June 2015
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10855464
Issued and outstanding 626,323,723 shares as of June 30, 2015
In six months, the OS was diluted by 580,067,155 DUH.
Adjusted for RS, the 250 million AS is actual 250 BILLION and current OS of 12,626,024 would actually be nearly 13 BILLION SHARES!!!!!
In less that a year, the OS has gone from 46 million to an adjusted 12.6 BILLION and that is not dilution??????????
LMFAO!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Also, the convertible notes were not paid off, the company has no cash.
Debt-to-Equity Conversions
As the terms of conversion to equity of the convertible debentures outstanding at December 31, 2014 of $303,491 have lapsed, these have been reclassified as Other Payables.
This is from the most recent 10Q
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11028738
MY information is from the filings, you will find them very helpful. In all my years I have never seen such massive dilution on any shell. That is why people aren't touching this POS. Anyone with a basic understanding of math won't ever come near this.
Recent LGIQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:43:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:08:29 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/13/2023 09:30:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 08:11:35 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 10/25/2023 09:04:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:03:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2023 10:48:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 04:28:19 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/29/2023 09:20:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 05:05:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:57:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:51:06 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM